Latest News in the pharma Industry

Policy & Regulation

First in the World Regulatory Approval of Novartis' Cosentyx in Japan for Both Psoriasis and Psoriatic Arthritis?

First in the World Regulatory Approval of Novartis' Cosentyx in Japan for Both Psoriasis and Psoriatic Arthritis?

30 Dec 2014

Read more 
Negative NICE Recommendation for Abraxane in Pancreatic Cancer

Negative NICE Recommendation for Abraxane in Pancreatic Cancer

30 Dec 2014

Read more 
Hospira Receives FDA Approval of Proprietary Analgesic Dyloject Injection

Hospira Receives FDA Approval of Proprietary Analgesic Dyloject Injection

30 Dec 2014

Read more 
Rx-360 Summary of FDA's Published Final Guidance for Industry: Specification of the Unique Facility Identifier System for Drug Establishment Registration

Rx-360 Summary of FDA's Published Final Guidance for Industry: Specification of the Unique Facility Identifier System for Drug Establishment Registration

29 Dec 2014

Read more 
Novo Nordisk Receives FDA Approval for Saxenda for the Treatment of Obesity

Novo Nordisk Receives FDA Approval for Saxenda for the Treatment of Obesity

24 Dec 2014

Read more 
BMS Receives Accelerated Approval of Opdivo (Nivolumab) from FDA

BMS Receives Accelerated Approval of Opdivo (Nivolumab) from FDA

23 Dec 2014

Read more 
Lynparza Approved by the FDA for the Treatment of Advanced Ovarian Cancer in Patients with Germline BRCA-Mutations

Lynparza Approved by the FDA for the Treatment of Advanced Ovarian Cancer in Patients with Germline BRCA-Mutations

22 Dec 2014

Read more 
Pozen’s Yosprala Receives Complete Response Letter from the FDA

Pozen’s Yosprala Receives Complete Response Letter from the FDA

22 Dec 2014

Read more 
CHMP Grants Actavis' Subsidiary Durata Therapeutics International, a Positive Opinion for Xydalba  for the Treatment of ABSSSI in Adults.

CHMP Grants Actavis' Subsidiary Durata Therapeutics International, a Positive Opinion for Xydalba for the Treatment of ABSSSI in Adults.

22 Dec 2014

Read more 
Successful FDA Inspection at Hovione

Successful FDA Inspection at Hovione

18 Dec 2014

Read more 
Rx-360 Summary of FDA’s Draft Guidance for Industry DSCSA Standards for the Interoperable Exchange of Information for Tracing of Certain Human, Finished, Prescription Drugs

Rx-360 Summary of FDA’s Draft Guidance for Industry DSCSA Standards for the Interoperable Exchange of Information for Tracing of Certain Human, Finished, Prescription Drugs

18 Dec 2014

Read more 
Janssen Launches Imbruvica, First-in-Class Treatment for Patients with CLL and MCL in UK

Janssen Launches Imbruvica, First-in-Class Treatment for Patients with CLL and MCL in UK

17 Dec 2014

Read more